Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Trulieve Cannabis Corp.

Trulieve Cannabis has the most retail locations of any MSO. Curaleaf is the largest MSO in terms of revenue.

2 Cannabis Stocks to Consider If the SAFE Banking Act Passes

NEW YORK , May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2023 after market close on May 17, 2023. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report First Quarter 2023 Financial and Operational Results

NEW YORK , May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc.  (CSE: CURA /OTCQX:  CURLF ) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that members of Curaleaf's executive management team will be participating in the following investor community conferences and events during May 2023. Wolfe Conference 2023 May 11, 2023   Matt Darin, Chief Executive Officer of Curaleaf, will be participating in the Cannabis Roundtable panel discussion from 2:35 – 3:00 PM EST.Curaleaf management will also be hosting investor meetings.

Curaleaf Announces May Conference Participation

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Cannabis stocks moved up sharply on Thursday on remarks by a U.S. senator about a potential committee hearing on the Secure and Fair Enforcement (SAFE) Banking Act.

Cannabis stocks rise as SAFE Banking measure gets potential hearing with Senate committee

US multistate cannabis operator Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) saw its fourth quarter revenue miss estimates after a “messy” quarter marred by retail closures and headcount reductions. For the three-month period to end December 31, 2022, Curaleaf generated $352.5 million in revenue, a 14% increase year-over-year, but below consensus estimates of $482 million.

Curaleaf misses estimates after "messy" 1Q for US multistate operator

Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2022 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Darin - Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Matt McGinley - Needham Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Andrew Partheniou - Stifel JMP Scott Fortune - ROTH MKM Ty Collin - Eight Capital Eric Des Lauriers - Craig-Hallum Operator Good day, and welcome to the Curaleaf Holdings Fourth Quarter 2022 Conference Call. All participants will be in a listen-only mode.

Curaleaf Holdings, Inc. (CURLF) Q4 2022 Earnings Call Transcript

Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITDA(1) of $73 million Operating cash flow of $46 million and cash on balance sheet of $163 million NEW YORK , May 1, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter and year ended December 31, 2022. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.

Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results

Canopy Growth

Compass

WM Technology

Tilray Brands

Cantor Fitzgerald said Friday it will no longer provide research coverage of 23 cannabis stocks because analyst Pablo Zuanic has departed the firm. Zuanic is now head of Zuanic & Associates, a consulting and research firm aimed at the cannabis sector, according to his LinkedIn profile and a website for the firm.

Cantor Fitzgerald discontinues cannabis stock coverage with analyst departure

Are US Pot Stocks A Buy In May? The post 3 Top Marijuana Stocks For May 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Top Marijuana Stocks For May 2023

Tilray Brands and Curaleaf Holdings shares both climbed nearly 10% on Thursday after a group of bipartisan US Congress members reintroduced the Secure and Fair Enforcement (SAFE) Banking Act in the House and Senate. The proposal would ensure that legal cannabis businesses have access to critical banking and financial services.

Tilray Brands, Curaleaf shares lead cannabis stocks higher as SAFE Banking Act reintroduced

NEW YORK , April 26, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022 after market close on May 1, 2023. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results

Top Marijuana Stocks To Know About Right Now The post 2 Marijuana Stocks For Your Cannabis Investing 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks For Your Cannabis Investing 2023

2 Marijuana Stocks For This Weeks Watchlist The post Investing In Marijuana Stocks 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Investing In Marijuana Stocks 2023

IBM's first-quarter results were “better than feared” after higher margins counteracted the computing firm's revenue miss, said Wedbush.

IBM impresses, good news for Curaleaf, and junior resource companies shine in the analyst calls of the week

In the most recent available quarterly results, revenues rose 7% year-over-year, but losses continued. In January, the company laid off 10% of its workforce and reduced operations in several states.

Curaleaf Faces a Potentially Decisive Year. Will Big States Make a Difference?

Cronos Group

It continues to be a long wait for the cannabis industry towards federal level legalization. It was recently reported that Democrat and Republican congressional representatives will file a bill to prepare for legalization.

3 Cannabis Stocks That Could 10X in a Legalization Scenario

Aurora Cannabis

SNDL Inc.

All three of these marijuana stocks have plunged; Aurora has been hit the hardest. Curaleaf is generating the highest operating cash flow of the group, but all remain unprofitable.

How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

U.S. multi-state cannabis producer Curaleaf Holdings Inc. CURLF, -0.24% on Wednesday said it will have to tweak its sales or sales forecasts for its fiscal 2021 and 2022, following a review of transactions made through its wholesale business and “additional material weaknesses” discovered in its accounting protocols. Management said it expects the restatement of the sales figures will lower 2021 sales by around 1.25%, and lower expected sales for 2022 by approximately 0.75%.

U.S. cannabis giant Curaleaf says it misstated revenue

Minor Reductions in Revenue of Approximately 1.25% and 0.75% for 2021 and 2022, respectively NEW YORK, April 19, 2023 /PRNewswire/ --  Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), announced today that the Audit Committee of the Company's Board of Directors (the "Audit Committee"), with the assistance of outside counsel and consultants and in discussion with the Company's auditors, has been conducting, after internal review by management,  a review of certain purchases and sales of products through the Company's wholesale channel to determine whether they had commercial substance, and to confirm the timing and appropriateness of the recognition of revenue from those transactions, mainly in the last quarter of 2021 and the first and second quarters of 2022. Further to this review, the Company has determined that it will make certain adjustments to the revenue figures reported in its previously issued (i) audited annual consolidated financial statements for the fiscal year ended December 31, 2021 (the "2021 Annual Financial Statements") and (ii) unaudited interim consolidated financial statements for the first, second and third quarters of the fiscal year ended December 31, 2022 (collectively, the "2022 Interim Financial Statements"), as well as other related flow through adjustments.

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

Curaleaf's recreational license renewal in New Jersey, a reversal of the state's Cannabis Regulatory Commission's (CRC's) earlier decision, is a positive development for the company according to Stifel GMP analysts.   “As a result, we no longer intend to revise our forecasts based on this past week's events and will wait for 4Q FY22 results to update our outlook, with a focus on gaining greater clarity on management's industry-high guidance of greater than $125 million 2023 free cash flow,” the analysts wrote in a note to clients.

Curaleaf's recreational license renewal in New Jersey ‘positive,' analysts say

Tomorrow, 'only' in states where it's legal, cannabis will be celebrated as part of the long-fabled 4/20 (April 20) holiday.

4 Cannabis Stocks to Watch Right Now

Curaleaf Holdings, Inc. guided to $125 million in free cash flow this year after exiting several tough state markets. The cannabis space remains a regulatory landmine with the license renewal drama in New Jersey.

Curaleaf: New Narrative Despite New Jersey Drama

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that today, Monday, April 17th, the Board of the New Jersey Cannabis Regulatory (CRC) reversed itself and voted to approve Curaleaf's adult use cannabis licenses.

NJ CRC Board Reverses Itself and Fully Approves Curaleaf's Adult Use License Renewals After Legal Challenge

Curaleaf Holdings Inc. CURLF, +4.35% CURA, +5.45% stock is up 4.2% after New Jersey Cannabis Regulatory Commission on Monday approved a renewal of the Massachusetts-based company's cultivation and retail licenses for adult-use in the Garden State, in a reversal of a decision last week, according to spokespeople for the commission and Curaleaf. The New Jersey Cannabis Control Commission met in an emergency session ahead of the expiration of Curaleaf's license later this week.

Curaleaf wins renewal for NJ licenses after emergency meeting of state's cannabis regulatory commission

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) are not yet updating their estimates for Curaleaf as the cannabis producer appeals the New Jersey Cannabis Regulatory Commission's (CRC's) vote against renewing its adult-use retail and cultivation licenses in the state as of April 21, 2023. Curaleaf said in a statement on April 14 that it has fulfilled the requirements necessary for the renewal of its licenses, it has never received any violation notices from the CRC to allow it to remedy the concern, and it will work with the CRC to ensure the renewal of its licenses.

News for Curaleaf Holdings, Inc. Stock (CURLF)